The drug works.
The behavior fails.
We fix that.
Ew2health gives medical weight-loss clinics a predictive view of GLP-1 adherence, dropout risk, and treatment effectiveness — so you can guide patients, not just measure them, toward lasting change.
GLP-1 DROPOUT
65% / year
AVG. WEIGHT LOSS ON GLP-1
15–20%
REGAIN AFTER STOPPING
~⅔ in 1 yr
Adherence forecast
On track · 14 days
The Problem
The leaky bucket.
GLP-1 prescriptions are growing. Long-term outcomes are not following.
Patients disengage — not because they don't care, but because the system feels unsafe and unsupported. Clinics absorb the cost: lost adherence, lost retention, lost lifetime value.
18-23%
annual growth of GLP-1 prescriptions
65%
loss of GLP-1 treatment revenues
45%
loss of GLP-1 patient lifetime value (LTV)
The Solution
Ew2health is the predictive behavioral infrastructure for obesity care.
We monitor behavior — not just biomarkers — to forecast where a patient is headed, up to 15 days ahead. Our patented Predictive Behavioral Analytics capability gives medical weight-loss clinics a predictive view of adherence, dropout risk, and treatment effectiveness. Creating a new operating model for obesity care.
What makes us unique
The only company that turns behavior into a predictive signal.
Traditional monitoring reacts to biomarkers. Ew2health predicts patient trajectory. Using behavioral intelligence, we forecast adherence, dropout risk, and treatment effectiveness up to 15 days ahead — helping clinics prevent dropout, improve adherence, and personalize GLP-1 care.
01
We monitor behavior, not just biomarkers — and that is what makes us predictive.
Our patented PBA (US Patent 11,633,160) reads how a person is living and forecasts their weight trajectory up to 15 days ahead.
02
We encourage frequent self-monitoring — building a unique, high-frequency dataset.
Patients self-monitor 3–4× per week without judgment, producing a longitudinal dataset competitors can't replicate.
03
We integrate into the workflow of medical weight-loss clinics — improving outcomes.
We catch disengagement before drop-out — clinics' biggest revenue leak — and enable personalized titration between appointments.
04
We are building a 3D biomarker architecture — the biological context behind the behavior.
We combine weight, glucose and VO₂max monitoring to help clinicians separate behavior issues from biological ones. Together with Roche and Garmin.
Coming soonA new category · Predictive Behavior Analytics
One signal. Two interfaces.
Behavior is the signal — captured on the patient's phone, decoded on the clinician's dashboard. Sinque is a two-sided platform: a consumer app patients actually use, and a clinical workspace that turns their behavior into early warnings.
What the patient does
Sinque app
- Daily weighing — the first step in behavior change needed to succeed.
- Personal weight trend forecast — giving users a 15 day head start to change.
- Safe and numberless — patients see their trend; professionals interpret the data.
What the clinician sees
Sinque clinical dashboard
- Early-disengagement flag — fewer weighings per week, surfaced before drop-out.
- Trajectory slope — slight changes in weight-loss speed reveal treatment effectiveness in real time.
- 15-day weight forecast — allowing for early interventions in titration and nutritional support.
US Patent 11,633,160 — Predictive Behavioral Analytics
Who We Serve
From clinics today to the infrastructure of metabolic care.
Ew2health serves the operators driving obesity care today, while building the behavioral intelligence layer the broader ecosystem will rely on tomorrow.
FOUNDATION
Medical weight-loss programs & clinics
GLP-1 clinics in the Netherlands, Brazil, and expanding to the US.
EXPANSION
Telemedicine & virtual clinic chains
Licensing the platform to scale behavioral intelligence across networks.
PLATFORM PARTNERSHIPS
Pharma · Medtech · Wearables
Intelligence layer for GLP-1. The clinical-grade solution for continuous monitoring.
Trusted infrastructure. Validated science.
Built with the leaders in metabolic health.
GLP-1s can drive weight loss. Behavior determines the outcomes. Ew2health gives clinics predictive behavioral intelligence to identify dropout risk early, personalize intervention, and improve retention at scale. The result: higher patient lifetime value, lower revenue leakage, and obesity care models that scale sustainably without adding operational complexity.
Investor information →